Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Diseases & Conditions
Neurofibroma
A comprehensive guide to the symptoms of neurofibroma, cancer risk, the role of plexiform neurofibromas, and the monitoring approach.
A neurofibroma is a tumor related to peripheral nerves. Many are benign and may appear as soft or rubbery lesions under the skin. Some occur sporadically, while others are associated with neurofibromatosis type 1 (NF1), a genetic disorder in which multiple neurofibromas may develop over time. Because the term can refer to lesions with different clinical significance, it is important to assess whether the tumor is solitary or part of a broader syndromic condition. [1][3][4]
Many patients first notice a neurofibroma because of a small lump, cosmetic concern, or mild local discomfort. In other cases, the lesion may not attract attention until it enlarges, becomes painful, or occurs in deeper tissues. Although most neurofibromas are benign, context matters greatly: location, number of lesions, age at onset, and the presence of other NF1-related findings can change both the level of concern and the follow-up plan. [2][3]
What symptoms can neurofibromas cause?
Small superficial neurofibromas may cause few symptoms beyond a visible or palpable lump. When symptoms do occur, they may include local tenderness, pain, altered sensation, or discomfort from pressure on nearby tissues. Deeper lesions can be harder to detect on physical examination and may come to attention because of pain or neurologic symptoms rather than a visible swelling. [1][4]
In some patients, the issue is less about pain and more about growth pattern. A lesion that enlarges, changes in texture, causes functional limitation, or is associated with persistent pain deserves closer evaluation. This is particularly important in people with NF1, because not every lump behaves the same way and some may require imaging or referral to a specialist team. [2][3][4]
What is plexiform neurofibroma, and why is it important?
The NCI defines plexiform neurofibroma as a tumor that grows along a nerve and its branches. This type is especially important because it is more strongly associated with NF1 and can involve larger, deeper, and more complex nerve pathways. Plexiform neurofibromas may be present from childhood and can enlarge over time, sometimes causing disfigurement, pain, or compression of nearby structures. [2][3]
They also matter because, in a subset of patients, they may transform into a malignant peripheral nerve sheath tumor. This does not mean that every plexiform neurofibroma is cancerous, but it does explain why sudden growth, increasing pain, new neurologic deficits, or a clear change in the lesion’s behavior should not be ignored. Monitoring decisions therefore depend not only on what the lesion is called, but on how it behaves over time. [2][3][4]
Are neurofibromas cancer?
Most neurofibromas are benign. However, the conversation becomes more nuanced when the lesion is multiple, deep, plexiform, or associated with NF1. In those settings, clinicians may be more alert for complications and for the rare possibility of malignant transformation. The key point is that the word “neurofibroma” alone does not answer every risk question; the surrounding clinical context is essential. [2][3][4]
This distinction matters for patients, because hearing “tumor” naturally creates anxiety. In practice, many neurofibromas are followed rather than removed immediately. What determines urgency is not simply the presence of the tumor, but whether it is growing, painful, functionally significant, cosmetically distressing, or suspicious in behavior. [1][2]
How are diagnosis and follow-up approached?
The diagnostic process begins with the history and physical examination. Clinicians look at the number of lesions, their distribution, whether other NF1 features are present, and whether the lesion causes pain or neurologic symptoms. Imaging may be needed if the lesion is deep, enlarging, or associated with functional complaints. In syndromic cases, the aim is not only to label a single mass, but to understand the broader pattern of disease. [1][3][4]
Follow-up depends on age, symptoms, lesion type, and whether NF1 is present. Some isolated superficial neurofibromas need little more than clinical observation. Others—especially plexiform lesions—may require periodic imaging and multidisciplinary review. The goal of surveillance is not to alarm the patient, but to detect important change early and to intervene at the right time if symptoms or complications emerge. [2][3]
When is treatment needed?
Treatment is not required for every neurofibroma. Some are observed only. Intervention may be considered when there is pain, functional impairment, progressive enlargement, pressure on nearby structures, or significant cosmetic burden. Surgery is one option in selected cases, but the decision depends on location, the relationship to the nerve, and the expected balance between benefit and possible neurologic risk. [1][2]
In NF1-associated disease, management is often broader than a single operation. Children and adults may need long-term follow-up for skin findings, neurologic issues, learning difficulties, skeletal problems, and tumor-related complications. This is why recognizing whether a neurofibroma is isolated or part of NF1 is clinically important. [3][4]
When should prompt evaluation be sought?
Prompt medical evaluation is recommended if a known lesion begins growing rapidly, becomes significantly painful, causes numbness or weakness, interferes with daily function, or changes suddenly in character. New deep pain or unexplained neurologic symptoms in a patient with NF1 also deserve timely assessment. These changes do not automatically mean cancer, but they should not be dismissed. [2][3][4]
A neurofibroma is often benign, but it is not always clinically trivial. Meaningful management depends on whether the lesion is solitary or syndromic, superficial or deep, stable or changing. Specialist evaluation is valuable when symptoms appear, the lesion enlarges, or NF1 is suspected. [1][3][4]
FAQ
What is a neurofibroma?
It is a nerve-related tumor that is often benign and may occur alone or as part of neurofibromatosis type 1. [1][3]
Is a neurofibroma cancer?
Most are not. However, some lesions—especially plexiform lesions in NF1—require closer follow-up because of higher clinical complexity and rare malignant transformation risk. [2][3]
What is plexiform neurofibroma?
It is a neurofibroma that grows along a nerve and its branches and is commonly associated with NF1. [2][3]
Does every neurofibroma need surgery?
No. Many can be monitored. Treatment is usually considered when symptoms, growth, functional effects, or concerning features are present. [1][2]
Is neurofibroma associated with NF1?
Yes. Multiple neurofibromas or plexiform lesions may be associated with neurofibromatosis type 1. [3][4]
References
- 1.MedlinePlus Medical Encyclopedia Image. *Neurofibroma*. 2024. https://medlineplus.gov/ency/imagepages/9694.htm
- 2.National Cancer Institute (NCI). *Definition of plexiform neurofibroma*. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plexiform-neurofibroma
- 3.MedlinePlus Genetics. *Neurofibromatosis type 1*. 2020. https://medlineplus.gov/genetics/condition/neurofibromatosis-type-1/
- 4.MedlinePlus Medical Encyclopedia. *Neurofibromatosis-1*. 2024. https://medlineplus.gov/ency/article/000847.htm
For more detailed information about this topic or to consult with our specialist physiotherapists, please contact us.
Contact Us